GlassScriptPhysician profile
Jeffrey D Watson
NPI 1376687822
$17,883.97
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,877 · 2020: $3,667 · 2021: $10K · 2022: $1,950.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,703.73 | 2019-2022 | |
| Mvp Orthopedics INC | $2,686.35 | 2020-2022 | |
| Stryker Corporation | $2,006.72 | 2019-2022 | |
| Smith+Nephew, INC. | $858.93 | 2019-2022 | |
| Orthofix Medical, INC. | $150.54 | 2019 | |
| Miach Orthopaedics, INC. | $147.63 | 2022 | |
| Bioventus LLC | $130.19 | 2022 | |
| Electronic Waveform Lab, INC. | $103.35 | 2021-2022 | |
| Depuy Synthes Sales INC. | $37.53 | 2022 | |
| Organogenesis INC. | $27.46 | 2022 | |
| Abbott Laboratories | $16.02 | 2019 | |
| Ermi LLC | $15.52 | 2021 |
Research and ownership
$28.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.